Marvel Biosciences Corp (TSE:MRVL)
TSXV:MRVL
Canadian Market
Holding TSE:MRVL?
Track your performance easily

Marvel Biosciences Corp (MRVL) Financial Statements

13 Followers

Marvel Biosciences Corp Financial Overview

Marvel Biosciences Corp's market cap is currently ―. The company's EPS TTM is C$-0.063; its P/E ratio is -1.82; Marvel Biosciences Corp is scheduled to report earnings on November 20, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Apr 24Jan 24Oct 23Jul 23Apr 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -307.31KC$ -210.36KC$ -497.59KC$ -1.03MC$ -693.27K
EBITDAC$ -307.31KC$ -210.36KC$ -497.59KC$ -1.03MC$ -693.27K
Net Income Common StockholdersC$ -307.31KC$ -232.81KC$ -518.30KC$ -1.05MC$ -716.33K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 217.69KC$ 577.67KC$ 316.98KC$ 556.62KC$ 1.00M
Total AssetsC$ 347.27KC$ 711.16KC$ 434.75KC$ 672.39KC$ 1.22M
Total DebtC$ 1.50MC$ 1.50MC$ 1.00MC$ 1.00MC$ 848.76K
Net DebtC$ 1.28MC$ 922.33KC$ 683.02KC$ 443.38KC$ -153.43K
Total LiabilitiesC$ 3.10MC$ 3.17MC$ 2.66MC$ 2.39MC$ 1.75M
Stockholders EquityC$ -2.76MC$ -2.45MC$ -2.23MC$ -1.72MC$ -528.62K
Cash Flow-
Free Cash FlowC$ -359.98KC$ -239.31KC$ -239.64KC$ -445.56KC$ -296.14K
Operating Cash FlowC$ -359.98KC$ -239.31KC$ -239.64KC$ -445.56KC$ -296.14K
Investing Cash Flow-----
Financing Cash Flow-C$ 500.00K--C$ 1.00M
Currency in CAD

Marvel Biosciences Corp Earnings and Revenue History

Marvel Biosciences Corp Debt to Assets

Marvel Biosciences Corp Cash Flow

Marvel Biosciences Corp Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis